NCT01434134View on ClinicalTrials.gov

Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Breast CancerHeart Failure
Interventions
DRUG

Metoprolol

Tablet, target dose 100 mg once daily

DRUG

Placebo

Tablet, target dose 100 mg once daily

DRUG

Candesartan

Tablet, target dose 32 mg once daily

DRUG

Placebo

Tablet, 32 mg once daily

Trial Locations (1)

1478

Akershus University Hospital, Lørenskog

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

University of Oslo

OTHER

collaborator

Norwegian Cancer Society

OTHER

collaborator

AstraZeneca

INDUSTRY

lead

University Hospital, Akershus

OTHER